Reinforcing integrated psychiatric service attendance in an opioid-agonist program: A randomized and controlled trial

被引:36
|
作者
Kidorf, Michael [1 ]
Brooner, Robert K. [1 ]
Gandotra, Neeraj [1 ]
Antoine, Denis [1 ]
King, Van L. [1 ]
Peirce, Jessica [1 ]
Ghazarian, Sharon [1 ]
机构
[1] Johns Hopkins Univ, Addict Treatment Serv BBRC, Dept Psychiat & Behav Sci, Sch Med,Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA
关键词
Methadone maintenance; Psychiatric comorbidity; Treatment adherence; Contingency management; SUBSTANCE USE DISORDERS; ADDICTION SEVERITY INDEX; PLACEBO-CONTROLLED-TRIAL; COOCCURRING DISORDERS; COCAINE DEPENDENCE; CONTINGENCY MANAGEMENT; COUNSELING ATTENDANCE; MEDICATION ADHERENCE; ABUSE TREATMENT; GROUP-THERAPY;
D O I
10.1016/j.drugalcdep.2013.06.005
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The benefits of integrating substance abuse and psychiatric care may be limited by poor service utilization. This randomized clinical trial evaluated the efficacy of using contingency management to improve utilization of psychiatric services co-located and integrated within a community-based methadone maintenance treatment program. Methods: Opioid-dependent outpatients (n = 125) with any current psychiatric disorder were randomly assigned to: (1) reinforced on-site integrated care (ROIC), with vouchers (worth $25.00) contingent on full adherence to each week of scheduled psychiatric services; or (2) standard on-site integrated care (SOIC). All participants received access to the same schedule of psychiatrist and mental health counseling sessions for 12-weeks. Results: ROIC participants attended more overall psychiatric sessions at month 1 (M = 7.53 vs. 3.97, p < .001), month 2 (M = 6.31 vs. 2.81, p < .001), and month 3 (M = < .001 vs. 2.44, p < .001). Both conditions evidenced reductions in psychiatric distress (p < .001) and similar rates of drug-positive urine samples. No differences in study retention were observed. Conclusions: These findings suggest that contingency management can improve utilization of psychiatric services scheduled within an on-site and integrated treatment model. Delivering evidenced-based mental health counseling, or modifying the contingency plan to include illicit drug use, may be required to facilitate greater changes in psychiatric and substance abuse outcomes. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 50 条
  • [21] A Randomized Controlled Trial Examining the Impact of an Anorectal Surgery Multimodal Enhanced Recovery Program on Opioid Use
    Reif de Paula, Thais
    Nemeth, Samantha K.
    Kurlansky, Paul A.
    Simon, Hillary L.
    Miller, Lydia K.
    Keller, Deborah S.
    ANNALS OF SURGERY, 2022, 275 (01) : E22 - E29
  • [22] Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BAR
    Chalabianloo, Fatemeh
    Fadnes, Lars Thore
    Assmus, Jorg
    Mordal, Jon
    Solli, Kristin K.
    Dale, Kjetil S.
    Andersen, Christina D.
    Zavenova, Silvia
    Ronning, Beathe H.
    Blomkvist, Andreas W.
    Ryssdal, Martin
    Butt, Wasifa S. J.
    Marciuch, Anne
    Ormen, Anne G.
    Ohldieck, Christian
    Loberg, Else-Marie
    Johansson, Kjell Arne
    TRIALS, 2025, 26 (01)
  • [23] Tapering Opioid Prescription Program for High-Risk Trauma Patients: A Pilot Randomized Controlled Trial
    Berube, Melanie
    Dupuis, Sebastien
    Leduc, Stephane
    Roy, Isabel
    Turcotte, Valerie
    Cote, Caroline
    Grzelak, Sonia
    Clairoux, Sarah
    Panic, Stephane
    Lauzier, Francois
    PAIN MANAGEMENT NURSING, 2022, 23 (02) : 142 - 150
  • [24] The VADO approach in psychiatric rehabilitation: A randomized controlled trial
    Gigantesco, Antonella
    Vittorielli, Michela
    Pioli, Rosaria
    Falloon, Ian R. H.
    Rossi, Giuseppe
    Morosini, Pierluigi
    PSYCHIATRIC SERVICES, 2006, 57 (12) : 1778 - 1783
  • [25] The VADO approach in psychiatric rehabilitation: A randomized controlled trial
    Gigantesco, A.
    Morosim, P.
    Vittorielli, M.
    Pioli, R.
    EUROPEAN PSYCHIATRY, 2008, 23 : S116 - S117
  • [26] Postpartum visit timing and the effect on visit attendance: A randomized controlled trial
    Kole-White, Martha B.
    Schlichting, Lauren
    Ayala, Nina K.
    Eger, Renee R.
    Howard, Margaret
    Mitta, Srilakshmi
    Lewkowitz, Adam K.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (01) : S554 - S554
  • [27] Randomized controlled trial of a comprehensive discharge program
    Jack, B.
    Paasche-Orlow, M.
    Anthony, D.
    Greenwald, J.
    Manasseh, C.
    Burniske, G.
    Forsythe, S.
    Johnson, A.
    O'Donnell, J.
    Chetty, V.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 389 - 389
  • [28] Experience corps: Results of a modified, randomized controlled trial of a senior service program on cognitive functions
    Carlson, M
    Frick, K
    Zeger, S
    Tielsch, J
    Saczynski, J
    McGill, S
    Fried, L
    Rebok, G
    Glass, T
    Hill, J
    Seeman, T
    GERONTOLOGIST, 2004, 44 : 434 - 435
  • [29] A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
    Richards, Erica M.
    Mathews, Daniel C.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Machado-Vieira, Rodrigo
    Niciu, Mark J.
    Duncan, Wallace C.
    Nolan, Neal M.
    Franco-Chaves, Jose A.
    Hudzik, Thomas
    Maciag, Carla
    Li, Shuang
    Cross, Alan
    Smith, Mark A.
    Zarate, Carlos A., Jr.
    PSYCHOPHARMACOLOGY, 2016, 233 (06) : 1119 - 1130
  • [30] A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
    Erica M. Richards
    Daniel C. Mathews
    David A. Luckenbaugh
    Dawn F. Ionescu
    Rodrigo Machado-Vieira
    Mark J. Niciu
    Wallace C. Duncan
    Neal M. Nolan
    Jose A. Franco-Chaves
    Thomas Hudzik
    Carla Maciag
    Shuang Li
    Alan Cross
    Mark A. Smith
    Carlos A. Zarate
    Psychopharmacology, 2016, 233 : 1119 - 1130